Over One-Third of HCV Patients Denied DAA Tx by Payers

https://www.medpagetoday.com/infectiousdisease/hepatitis/73368 Highest among commercial insurers, increased over study period More than a third of chronic hepatitis C (HCV) patients were denied access to direct-acting antiviral (DAA) treatment by their insurance provider, researchers found. Among patients prescribed DAAs, 35.5% (95% CI 34.5%-36.5%) had their prescriptions denied by their insurer, reported Charitha Gowda, MD, of Ohio State […]

Healthcare/Insurance… just your basic FOR PROFIT BUSINESS

Half of hepatitis C patients with private insurance denied life-saving drugs https://medicalxpress.com/news/2018-06-hepatitis-patients-private-denied-life-saving.html The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in […]

I will believe this when the CDC and DEA make similar statements and take action.

FDA Commissioner Says FDA Will Listen to Chronic Pain Patients About Opioids www.themighty.com/2018/05/fda-chronic-pain-patients-opioids/ In a blog post published on Monday, Scott Gottlieb, the Food and Drug Administration commissioner, said the FDA is listening to opioid-related concerns from patients with chronic pain. “We’ve heard the concerns expressed by these individuals about having continued access to necessary […]